Poziotinib inhibits HER2 mutant-driven therapeutic resistance and multi-organ metastasis in breast cancer. Kalra R, Chen CH, Wang J, Salam AB, et al. Cancer Res 2022 Jun 23. pii: 705013. doi: 10.1158/0008-5472.CAN-21-3106.

Read + Share

Amedeo Smart

Independent Medical Education

Kalra R, Chen CH, Wang J, Salam AB, et al. Poziotinib inhibits HER2 mutant-driven therapeutic resistance and multi-organ metastasis in breast cancer. Cancer Res 2022 Jun 23. pii: 705013. doi: 10.1158/0008-5472.CAN-21-3106.
PMID: 35736563